Lung Cancer

Tecemotide (INN; emepepimut-S (USAN); formerly known as BLP25 or EMD 531444) is a synthetic lipopeptide that is used as antigen in an investigational therapeutic cancer vaccine (formerly known as Stimuvax, L-BLP25, BLP25 liposomal vaccine, or BLP25 liposome vaccine).

Read more in the app

Effect of respiratory phase on three-dimensional quantitative parameters of pulmonary subsolid nodules in low-dose computed tomography screening for lung cancer - EurekAlert!

New Hope for Lung Cancer: Scientists Develop Targeted Genetic Treatment

Smart nanoparticles launch genetic attack on lung cancer and cystic fibrosis

New biomarker may guide best use of KRAS inhibitors in lung cancer - EurekAlert!

Identifying lung cancer in Emergency Department patients outside national lung cancer screening guidelines - EurekAlert!

NRG Oncology adds new committee leaders in lung cancer and imaging - EurekAlert!

Detecting lung cancer 4 months earlier at the GP using artificial intelligence - EurekAlert!

Unraveling the oncogenic potential of microRNAs in lung cancer - EurekAlert!

Scientists Discover Unexpected Link Between Diet And Lung Cancer Risk

Eat better, breathe easier? Research points to link between diet, lung cancer - EurekAlert

Eat better, breathe easier? Research points to link between diet, lung cancer

Breakthrough combination therapy tackles drug resistance in lung cancer with common KRAS mutation - EurekAlert

Lung Cancer Is Rising in Non-Smokers, And This Could Be Why

Research pinpoints weakness in lung cancer's defenses

Copper-detection tool designed to discover possible chelation target for lung cancer

Princeton Chemistry develops copper-detection tool to discover possible chelation target for lung cancer - EurekAlert

Chinese Medical Journal article sheds light on the global lifetime risk of lung cancer - EurekAlert

Fibroblastic reticula cells can organize T cells in the fight against lung cancer

Signs of Lung Cancer Can Now Be Detected When You Exhale

AI analysis of PET/CT images can predict side effects of immunotherapy in lung cancer - EurekAlert